ClinicalTrials.Veeva

Menu

Difference of Gastric Microbiota in the Process of Correa's Model.

S

Shandong University

Status

Unknown

Conditions

Atrophic Gastritis
Gastric Microbiota
Gastric Cancer
Intraepithelial Neoplasia
Intestinal Metaplasia
Helicobacter Pylori
Non-atrophic Gastritis

Study type

Observational

Funder types

Other

Identifiers

NCT02833363
2016SDU-QILU-08

Details and patient eligibility

About

Helicobater pylori plays an important role in the development of gastric cancer. Eradication therapy can reducing the morbidity of gastric cancer, but can't totally prevent it especially when atrophy and more serious precancerous lesions already happened. Prior studies found the gastric bacterial difference among gastritis, intestinal metaplasia and gastric cancer. However, they didn't reach an agreement. Correa's model is widely accepted in the development of gastric cancer. The pathological change makes a more suitable environment for bacteria to overgrowth. This study are designed to analyze the gastric microbial difference of non-atrophic gastritis, atrophic gastritis, intestinal metaplasia, intraepithelial neoplasia and gastric cancer.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients go through a gastric endoscopy examination with non-atrophic gastritis, atrophic gastris, intestinal metaplasia, intraepithelial neoplasia and gastric cancer.
  2. Did not take any antibiotics,PPI,probiotics and chinese herbs in the past one month,and took less than one week in the past three months before the gastroscopy examination.
  3. Sign the informed consent.

Exclusion criteria

  1. Had been taken Helicobacter pylori eradication therapy before.
  2. Previous gastrointestinal surgery.
  3. During the pregnancy and lactation period.
  4. With any serious diseases like liver failure,heart failure,renal failure,malignant tumor,alcoholism or any other disease that may effect the result.
  5. With any mental problems.

Trial design

50 participants in 5 patient groups

patients with non-atrophic gastritis
Patients with gastritis
Patients with intestinal metaplasia
Patients with intrepithelial neoplasia
Patients with non-cardia gastric cancer

Trial contacts and locations

1

Loading...

Central trial contact

Yanqing Li, MD,PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems